BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of over 1000 found
  Current Search:  heart: 8373, block: 2994     

HTML
100%
Sunnybrook performs minimally invasive bypass surgery
Fuad Moussa (right) with his patient, Doug Boychuk, five weeks after Mr.

Boychuk received minimally invasive bypass surgery at Sunnybrook.

By Laurie Legere Sunnybrook's Schulich Heart Centre became the first centre in Toronto to...

Hospital News:  Jul 4 2009 1:44PM
Matching: heart block
Find similar documents
HTML
100%
Novel targeted therapy shows promise to eliminate leukaemia stem cells
A piece of research has shown that it is possible to eliminate stem cells related to human acute myeloid leukemia (AML), a notoriously treatment-resistant blood cancer, using a new targeted therapy.

Associate Professor Richard Lock, from...

NetIndia123.com:  Jul 4 2009 4:44PM
Matching: heart block
Find similar documents
HTML
100%
Novel targeted therapy shows promise to eliminate leukaemia stem cells
Washington, July 3 : A piece of research has shown that it is possible to eliminate stem cells related to human acute myeloid leukemia (AML), a notoriously treatment-resistant blood cancer, using a new targeted therapy.

Associate Professor...

NewKerala.com:  Jul 4 2009 2:26PM
Matching: heart block
Find similar documents
HTML
100%
Deadly Leukemia Stem Cells Found And Eliminated By New Targeted Therapy
New research describes a molecular tool that shows great promise as a therapeutic for human acute myeloid leukemia (AML), a notoriously treatment-resistant blood cancer.

The study, published by Cell Press in the July 2nd issue of the...

Medical News Today:  Jul 4 2009 7:48AM
Matching: heart block
Find similar documents
HTML
100%
New targeted therapy finds and eliminates deadly leukemia stem cells
New research describes a molecular tool that shows great promise as a therapeutic for human acute myeloid leukemia (AML), a notoriously treatment-resistant blood cancer.

The study, published by Cell Press in the July 2nd issue of the...

The Hindu:  Jul 4 2009 4:12AM
Matching: heart block
Find similar documents
HTML
100%
New Therapy Eliminates Deadly Leukemia Stem Cells
(Ivanhoe Newswire) A recent study describes a novel therapeutic approach which significantly advances the fight against the deadly human acute myeloid leukemia (AML), a notoriously treatment-resistant blood cancer.

AML is a cancer of the...

HealthScout:  Jul 4 2009 2:05AM
Matching: heart block
Find similar documents
HTML
57%
Mental health program on chopping block
program that had become a symbol of waste and inefficiency in North Carolina's troubled system of mental health care.

But some advocates for the mentally ill say that program has improved from its early days, and now provides basic but...

Raleigh News & Observer:  Jul 4 2009 3:48PM
Matching: block
Find similar documents
HTML
57%
Mental health program on chopping block
RALEIGH -- State legislators intend to phase out a program that had become a symbol of waste and inefficiency in North Carolina's troubled system of mental health care.

But some advocates for the mentally ill say that program has improved...

Raleigh News & Observer:  Jul 4 2009 10:19AM
Matching: block
Find similar documents
HTML
57%
Phase III Study Showed Lucentis Improved Vision In Patients With Branch Retinal Vein Occlusion
Genentech, Inc.

announced today that the Phase III study BRAVO showed Lucentis (ranibizumab injection) improved vision, as measured by the primary endpoint of mean change from baseline in best-corrected visual acuity at six months, in...

Medical News Today:  Jul 4 2009 9:13AM
Matching: block
Find similar documents
HTML
57%
Ms Antisense Drug Shows Early Promise, But Long-term Benefit Remains Unknown
A new study suggests another way to target VLA-4 as a strategy for relapsing MS: use antisense oligonucleotides to prevent the key cell adhesion molecule from being produced in the first place.

SEATTLE-Inhibiting migration of lymphocytes...

Neurology Today:  Jul 4 2009 4:20AM
Matching: block
Find similar documents
HTML
57%
New drug hits leukemia early
A new drug can halt budding leukemia in mice by binding to a key protein on the surface of blood cells predisposed to becoming cancerous, researchers report in the July 2 Cell Stem Cell.

This and other studies have paved the way for...

Science News Online:  Jul 4 2009 2:17AM
Matching: block
Find similar documents
HTML
57%
Parkinson's drugs show promise in resistant TB
* Drugs could be used to fight dangerous forms of TB * Compounds already proven in humans CHICAGO (Reuters) - Drugs used to treat Parkinson's disease show promise as a new way to stem the rise of drug-resistant forms of tuberculosis, U.S.
Reuters Health:  Jul 4 2009 12:09AM
Matching: block
Find similar documents
HTML
100%
Bone Marrow Extract Improves Cardiac Function
Using a novel, closed-chest, ultrasound-guided injection technique developed by Yeghiazarians and his colleagues, the team administered three different groups of mice with bone marrow cells, bone marrow cell extract, or saline (for the...
Medical Breakthroughs:  Jul 3 2009 7:31AM
Matching: heart block
Find similar documents
HTML
100%
First degree atrioventricular block, and ingested foreign bodies
Data from the Framingham Heart Study, reported in JAMA, challenge the conventional view that an incidental finding of a prolonged PR interval on the ECG is entirely benign.

During a long follow up period, individuals with a PR...

OnMedicanet:  Jul 3 2009 8:59AM
Matching: heart block
Find similar documents
HTML
100%
Colloid preload increases cardiac output after spinal anesthesia for cesareans
MedWire News: Administering crystalloid IV fluids before the induction of spinal anesthesia for cesarean delivery increases maternal cardiac output during the first 5 minutes after spinal anesthesia, say researchers.

However, they note...

MedWire News:  Jul 3 2009 12:22AM
Matching: heart block
Find similar documents
HTML
100%
New Targeted Therapy Finds And Eliminates Deadly Leukemia Stem Cells
New research describes a molecular tool that shows great promise as a therapeutic for human acute myeloid leukemia (AML), a notoriously treatment-resistant blood cancer.

The study, published in the July 2nd issue of the journal Cell Stem...

Science Daily:  Jul 3 2009 10:06PM
Matching: heart block
Find similar documents
HTML
100%
Therapy Eliminates Deadly Leukemia Stem Cells
A recent study describes a novel therapeutic approach which significantly advances the fight against the deadly human acute myeloid leukemia (AML), a notoriously treatment-resistant blood cancer.

AML is a cancer of the white blood cells...

Red Orbit:  Jul 3 2009 7:43PM
Matching: heart block
Find similar documents
HTML
100%
Immune Therapy Versus Leukemia Stem Cells
Via EurekAlert!

, an example of progress in using the immune system to target specific cells for destruction: acute myeloid leukemia (AML) "is a cancer of the white blood cells that has an extremely poor prognosis and does not respond well...

Longevity Meme:  Jul 3 2009 6:06PM
Matching: heart block
Find similar documents
HTML
100%
New Targeted Therapy Finds and Eliminates Deadly Leukemia Stem Cells
Health Conditions : Cancer : Leukemia New research describes a molecular tool that shows great promise as a therapeutic for human acute myeloid leukemia (AML), a notoriously treatment-resistant blood cancer.

The study, published by Cell...

Disabled World:  Jul 3 2009 2:24PM
Matching: heart block
Find similar documents
HTML
57%
Single Injection Paravertebral Block for Major Cancer Breast Surgery
Report Shows Shift in Starting Salaries for Physicians 2.

2008 Exclusive SurveyEarnings: Good news for primary care income 3.

Single Injection Paravertebral Block for Major Cancer Breast Surgery.

MDLinx:  Jul 3 2009 8:50PM
Matching: block
Find similar documents
HTML
57%
Week in Review: June 29-July 2, 2009
(SmarTrend(R) Week In Review via COMTEX) -- % Change ------------------------------ Index Close Week YTD ------------------------------------------------------ DJIA 8280.74 -1.87% -5.65% NASDAQ 896.42 -2.45% -0.76% S&P 500 1796.52 -2...
TMC Net:  Jul 3 2009 10:39AM
Matching: block
Find similar documents
HTML
57%
Sorin Group Announces Regulatory Approval and First Implants of New-Platform FACIL and REPLY Pacemakers in Jap
Sorin Group, (MIL:SRN) (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announced today the Ministry of Health, Labor and Welfare (MHLW) approval to market the FACIL&#8222...
Genetic Engineering News:  Jul 3 2009 6:48AM
Matching: block
Find similar documents
HTML
57%
Sorin Group Announces Regulatory Approval and First Implants of New-Platform FACIL and REPLY Pacemakers in Jap
- Sorin Group, (MIL:SRN) (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announced today the Ministry of Health, Labor and Welfare (MHLW) approval to market the FACIL and...
DiGiTAL50:  Jul 3 2009 6:44AM
Matching: block
Find similar documents
HTML
57%
Sugammadex and rocuronium accelerates reversal of neuromuscular blockade versus succinylcholine
MedWire News: Reversal of rocuronium-induced neuromuscular blockade with sugammadex is much faster than spontaneous recovery from succinylcholine, say researchers.

Succinylcholine has the shortest duration of action of all currently...

MedWire News:  Jul 3 2009 12:22AM
Matching: block
Find similar documents
HTML
57%
Jul 2, 2009
-- Genentech, Inc.

announced today that the Phase III study BRAVO showed Lucentis (ranibizumab injection) improved vision, as measured by the primary endpoint of mean change from baseline in best-corrected visual acuity at six months, in...

Genentech:  Jul 3 2009 2:59AM
Matching: block
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.